chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 40 minutes after the vaccine i noted my throat was dry  and my voice started to change and it was deep and scratchy, The change in voice got worse as i was speaking to my friend so i went to the ED (building next to where I work). I had no problems breathing but was eventually treated for anaphylaxis  with  epi, prednisone, benadryl, and pepcid
Hives (urticaria) randomly appearing all over body, sometimes spontaneously but sometimes in reaction to skin pressure. Hives seem to recur mostly in the morning, in the evening, and in the middle of the night. Hives mostly appear on legs, trunk, armpits, neck, scalp. Other symptoms include itchy palms and flushing in and around the ears. Managing symptoms successfully with Benadryl or 24-hr Zyrtec, usually taken before bed, and hydrocortisone cream.
devel diffuse maculopapular rash on 8SEP;no other sx;reporter states reported similar rash in another pt w/in the last month w/same lot MMR;
Itching at site of injection.  Turned bright red about 1 inch in diameter around injection site and was very hot and tender to the touch.  Sore throat started at 9:30PM and was diagnosed with Strep throat and upper respiratory infection the next day on 08/27/2011.
swelling & redness over the pt upper eyelid & erythema; 2 erythematous lesions over 1 cm/1cm of a lt thigh;
Pt. vaccinated @ approx. 1445.  1448- brought  to first aid station by medic in wheelchair stating that her lt arm was slightly itchy and her tongue "was tingling".  Pt. AA&O x3. Lungs clear to auscultation bilaterally. Pt. had fine macular red rash over top of left lateral and anterior arm that spread medially across the upper portion of her chest.  Stated that rash was faintly itchy.  BP- 140/78-HR- 112 R - 22. Pt. placed in supine position for 15 minutes.  Lungs remained clear. Rash fading to light pink at 15 minutes and tongue no longer tingling. Pt. able to call home and speak w/o difficulty.  Pt. placed in sitting position for 10 minutes. 1505- BP-134/76 - HR - 80 r - 16. Pt. able to stand w/o difficulty @ 1515. Lungs clear bilaterally and rash no longer visible on Lt arm and only faintly pink on her chest.  Pt. stated that she "feels normal" and is not dizzy or lightheaded.  BP-130/78 HR- 80 RR- 16.  Pt. escorted to her car my medic and sent home in stable condition.
developed an unspecified rash; This spontaneous report has been received from a physician via company representative. concerning a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not provided.  In September 2013 (reported as 7 years ago), the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (frequency, route, lot number and expiration date were not provided) for prophylaxis.         In September 2013 (reported as 7 years ago), the patient developed unspecified rash shortly after received the dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL). The reporter stated that the patient received the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) during a different office visit on an unknown date.   The outcome of rash was reported as resolved. The causal relationship between rash and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was not provided.
Fatigue; Delayed arm reaction; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced delayed arm reaction/injection site muscle reaction and fatigue.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 23 Dec 2020, prior to the onset of the events, the patient received their dose of mRNA-1273 (Batch Number: Unknown) for prophylaxis of COVID-19 infection.  On an unspecified date, 7-9 days post-injection, the patient experienced some sort of reaction including delayed arm reaction and fatigue.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events delayed arm reaction and fatigue was not reported.  The outcome of the events, delayed arm reaction and fatigue was not reported.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
At first it started with the injection site then spread down my arm; My legs are so sore I can hardly walk; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730), via an unspecified route of administration on the right arm on 25Mar2021 at 15:30 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included implant birth control (MANUFACTURER UNKNOWN) from an unknown date. The patient was allergic to sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Mar2021 at 16:30, at first it started with the injection site then spread down her arm and then her legs are so sore that she can hardly walk. However, her arm stopped hurting and legs started hurting instead. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the adverse events. The clinical outcomes of the events leg soreness and vaccination site pain were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Numbing of lips, face, nose cavity. Thickening tongue. Weight on chest. Symptoms consistent with my response to both ibuprofen and strawberry allergies except less severe and no hives. Lasted about 4-6 hours.
Immediately after receiving the shot, I could taste metal or the medicine in my mouth.   After about 5 minutes, then my lips started to sting.  This all lasted for about 1.5 hours.
redness in the area of the shot / about the size of her hand; This case was reported by a consumer via and described the occurrence of injection site erythema in a 90-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th April 2021, the patient received the 1st dose of Shingrix. In April 2021, 1 week after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was unknown.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional details were provided as follows: The reporter reported this case for his/her aunt(patient). The patient had her Shingrix vaccine a week before reporting date. The reporter asked whether it was normal for patient to have redness in the area of the shot (about the size of her hand) a week later. The reporter also asked if it was common have redness in the area after a week. No further information available.
This spontaneous report as received form a nurse refers to a 9 months 6 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medication were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were information.
Information has been received from a physician concerning a female who on 25-MAR-2008 was vaccinated with her second dose of GARDASIL (lot# not reported).  Immediately after vaccination the patient experienced numbness at the injection site.  It was reported that the numbness was transient, lasting just a few seconds.  The numbness resolved as soon as the patient relaxed her arm after the vaccination.  Additional information has been requested. Follow up was received on 12-MAY-2008 from the nurse. She stated she does think the numbness was related to GARDASIL. She does not have any additional information and does not want to receive any further correspondence. Additional information was received on 20-MAY-2008. No further information to provided. Not a vaccine reaction. Patient tensed arm which cut off blood flow resulting in numbness.
Information has been received from a registered nurse concerning a 39-month-old male with no pre-existing allergies, birth defects, or medical conditions who on 05-APR-2005 was vaccinated IM in the right leg with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 626689/0651H). There was no illness at the time of vaccination. On 10-JUL-2007, the patient was diagnosed with varicella. There were no adverse events following prior vaccinations. There were no relevant diagnostic tests or laboratory data. Additional information has been requested.
At 5 days post vaccination, patient developed severe left shoulder pain, originally thought to be secondary to chronic shoulder pain and a recent fall, over the next three days it progressed to swelling, severe pain, and limited ROM. He ended up being admitted to the hospital and CT scan showed development of significant soft tissue infiltration around sternum and sternoclavicular joints. This was originally thought to be infectious, but he never developed a fever or leukocytosis and we feel this was most likely an inflammatory process. I have no idea if this was actually a vaccine side effect, but given the proximity in both time a location and the known complication of shoulder pain with the vaccine, it seems reasonable to give you the information to monitor for other similar cases.
Shoulder Pain and reduced range of motion since immunization on 12/19/2019. Patient has been exercising to increase range of motion. Pain level has decreased but is still present.
Pneumonia vaccine administered January 8, 2007 -later in the day developed extreme arm soreness, woke up next morning with left arm inflammed and sore.  Went to Doctor January 10 - cellulitis - prescribed Levaquin 500mg for 7 days.  Return to doctor January 12 for follow up. 03/01/07-records received:visit of 1/10/07-fever 102 arm sore, swelling and redness, left arm erythematous partially extending to under left arm, tender no discharge. follow up visit of 1/12/07-cellulitis improved. left arm no erythema but mild discoloration at site, non tender
Face paralysis that lasted 2 hours; A spontaneous report was received from a healthcare professional concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed face paralysis that lasted 2 hours.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, approximately 30 minutes prior to the onset of the event, the patient received their a dose of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  30 minutes following vaccination, the patient began to experience facial numbness. They experienced facial paralysis for 2 hours. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The event, face paralysis that lasted 2 hours, was considered resolved on an unknown date.; Reporter's Comments: This case concerns a female patient, who experienced a serious unexpected event of facial paralysis. The event of facial paralysis occurred 30 min (same day) after first dose of mRNA-1273, lot # unknown. Treatment details were not provided. Based on the current available information and temporal association between the use of the product and onset of the events a causal relationship cannot be excluded.
Myalgia, Arthralgia,  Fatigue, Chills Narrative:
Pt vaccinated with DTP/OPV/HIB 8 hrs following injections pt crying steadily & limp unable to stand or sit even propped up. Mentally quite "spacey" temp 101F on acetaminophen all night & sleep was disturbed. see WORM for more details.
Pt. states that after receiving the 1st dose of Moderna   03/08/2021, started experiencing symptoms 03/08/2021 (same-day) of shortness of breath and pain in the left arm. Extreme pain radiating down to the hand and up to the shoulder continuing until current. Primary visit resulted in pain management with no other recommendations. Pt. states that with pain management symptoms still continue.
chest discomfort; palpitations; flu-like symptoms; general malaise and feeling lousy; lingering symptoms; it's waxing and waning but he's still really quite ill; This is a spontaneous report received from a contactable reporter(s) (Other HCP), Program ID: (177478).  A 67-year-old male patient received BNT162b2 (COMIRNATY), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "fairly extensive cardiac history" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 Immunisation; Covid-19 vaccine (First Booster Dose; unknown manufacturer), for Covid-19 Immunisation. The following information was reported: CHEST DISCOMFORT (non-serious), outcome "not recovered"; PALPITATIONS (non-serious), outcome "not recovered"; INFLUENZA LIKE ILLNESS (non-serious), outcome "not recovered", described as "flu-like symptoms"; MALAISE (non-serious), outcome "not recovered", described as "general malaise and feeling lousy"; FEELING ABNORMAL (non-serious), outcome "not recovered", described as "lingering symptoms; it's waxing and waning but he's still really quite ill". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that the patient had a second COVID booster and about a day or two after that began to experience some chest discomfort, palpitations and had a very extensive cardiac workup since then, which had all been negative. Then during that time had also developed fairly significant, just general malaise and feeling lousy, kind of flu like symptoms. Again, workup was all negative for infectious causes and the only real factor was that second COVID booster. He still had lingering symptoms; it was waxing and waning but he was still really quite ill. He would be seeing a new cardiologist in mid-late July.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
5 weeks post vaccine early in the morning about 4:30AM I woke up with severe pain in my chest on the left side. On 1/28 went to the local urgent care because I had chest discomfort but was released after some time. Later that night I went to the another hospital where I was later admitted. There various test were performed and was later diagnosed with Pericarditis and so far has been treated with culture scene as an anti-inflammatory med to help with the discomfort. I have a F/U appointment scheduled for 2/17/2022.
dizziness; soreness; Feeling abnormal; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN (soreness) and FEELING ABNORMAL (Feeling abnormal) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     Concomitant products included METHADONE for Addiction, NIFEDIPINE for Blood pressure high, MULTIVITAMINS [VITAMINS NOS], FISH OIL and VITAMIN D NOS for an unknown indication.   On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced DIZZINESS (dizziness), PAIN (soreness) and FEELING ABNORMAL (Feeling abnormal). At the time of the report, DIZZINESS (dizziness), PAIN (soreness) and FEELING ABNORMAL (Feeling abnormal) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient used Anti Cholesterol to Lower Cholesterol ,Anti-Acid Reflux For Acid Reflux, Multi-Vitamin,Fish oil, Vitamin D For wellness. No treatment medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.
an expired dose was administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received HAV (Havrix) (batch number 72T95, expiry date 9th August 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th August 2022, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 30th August 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-DEC-2022 Reporter's Comment: The medical assistant reported that the patient received an expired dose of Havrix. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow up. Additional Supportive Information: The use of Havrix dose, which was already expired on 9th August 2022, which led to expired vaccine used.
Information has been received from a registered nurse, concerning a female patient, who on an unspecified date was vaccinated with GARDASIL ,0.5ml intra muscularly. The registered nurse reported that the patient developed tingling in both her hands, chills and hot flashes after receiving the vaccine. It was not specified by the registered nurse when the symptoms developed or how many doses of the vaccine the patient had received. The registered nurse mentioned that "the patient may have been coming down with the flu at this time." The patient sought medical attention through a telephone call. Additional information has been requested.
This spontaneous report was received from a medical assistant concerning multiple unspecified patients of unknown age and gender. No concurrent conditions or medical history were reported. On an unknown date, the patient were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot # L003227 Expiration date: 13-OCT-2016) (dose, route and anatomical location of administration were not reported). No adverse effects reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
After few moments of receiving multiple vax and Gardasil, patient had a syncope, blood pressure dropped. She recovered. 06/06/07-records received. Vaccine record documents on 5/30/07 Gardasil lot# 0522U, Varicella Lot #0455U, Menactra lot#U2277AA, Hepatitis A 2 lot#0246U. After vaccination patien left room and had loss of consciousness for 10 seconds. BP 88/54. Felt better after resting. Walked out of office with mother
cold chills; felt rough; Initial information regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional on 06-Nov-2020.  This case was linked to case 2020SA314521 (Cluster case).  This case involved patient (with unknown demographics) who reported of suffering from cold chills(chills) for which the patient had to lay down and also complained of feeling rough (feeling abnormal), when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, family history and concomitant medication were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route at aan unknown administration site for prophylactic vaccination.   On an unknown date, the patient reported of having cold chills (chills) for which the patient had to lay down and also complained of feeling rough for few hours (feeling abnormal) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory test was been reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the event outcome was reported as unknown for all the events.  There will be no information available on the batch number for this case.
This spontaneous report was received from a registered nurse and refers to a 6 months old patient of unknown gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On an unknown date, at 6 months of age, the patient was vaccinated with VAQTA 25/0.5 (units not provided) injection, lot # N005796 with expiration date on 26-MAY-2018 (dose and route of administration were not reported) (product use in unapproved population, drug administered to patient of inappropriate age). No adverse effects were reported.
13NOV95 evening pt c/o sore throat & neck;mom states no fever;14NOV sides of neck large, sore to touch;no other complaints;mom states pt ill enough to take to MD-mom called because read fact sheets felt pt had mumps
10 mins from recieving injection client became pale. ammonia used with minimum improvement, miminum respone to verbal stimuli c/o chilling and numbness to tongue Ems Called
Information has been received from a registered nurse concerning an adolescent female who on 11/15/2001 was vaccinated with a dose of varicella vaccine. On 11/20/2001, the pt developed a vesicular rash over her entire body. There were no other symptoms reported. The pt sought unspecified medical attention. No further info is expected.
Patient with single J+J vaccine April 2021 who admitted with COVID PNA and encephalopathy who discharged from hospital on 2/1/22 on comfort care and subsequently died.
Information has been received from a consumer concerning a her 4 year old son with allergy to metals and a history of high fever in approximately in August, 2003 (required emergency room visit but was not admitted to the hospital); who on 10-FEB-2004 was vaccinated with MMR II (Lot # not available). Concomitant therapy included DTaP, poliovirus vaccine and PREVNAR and other 2 unspecified vaccines, all given approximately in March, 2003. The consumer reported that the day after receiving the MMR II, on 11-FEB-2004, the patient was seen with signs of autism (onset date reported by the same consumer as "somewhere in 2005"). Per mother, her son "had difficulties putting two words together like mama and one day he woke up and did not look at me directly but instead tilted his head towards the ceiling and then looked down and turned far left or right and he started to repeat words over and over again". The consumer also reported that the patient walked on tippy except the toe nails are down. An unspecified biological test was performed with unknown results. At the time of the report, the patient had not recovered. The patient sought medical attention and was seen by a physician. Upon internal review, autism was determined to be an other important medical event. Additional information has been requested.
Pt has sleep problems on and off but they have aggravated after vaccine; sleeping in 3 hours interval 9/29 dizziness and lightheadedness started has been taking medication; hoarseness started today. At least no arm pain with vaccine this time.